Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MOR | AMGN | GILD | CELG | VRTX |
| Company | Morphosys Ag ADR | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.02 | 264.63 | 66.25 | 108.01 | 394.72 |
| High | 18.04 | 269.33 | 66.75 | 108.59 | 396.98 |
| Low | 17.90 | 260.68 | 66.16 | 107.27 | 391.25 |
| Last | 17.95 | 268.65 | 66.59 | 108.24 | 394.12 |
| Change | -0.10 | +5.90 | +0.43 | +0.11 | +0.64 |
| % Change | -0.55% | +2.25% | +0.65% | +0.10% | +0.16% |
| Volume | 143,776 | 1,923,947 | 5,002,658 | 191,230,496 | 823,061 |
| 20-Day Average Volume | 414,564 | 2,159,968 | 6,153,123 | 16,188,930 | 903,031 |
| Previous Close | 18.05 | 262.75 | 66.16 | 108.13 | 393.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.08 | 272.56 | 69.88 | 108.17 | 405.45 |
| 20-Day Raw Stochastic | 8.57% | 29.01% | 6.65% | 63.25% | 6.52% |
| 20-Day Relative Strength | 60.75% | 43.79% | 29.48% | 64.69% | 36.60% |
| Weighted Alpha | +76.52 | +7.59 | -24.84 | +46.30 | +15.42 |
| Today's Opinion | 88% Buy | 56% Sell | 100% Sell | 100% Buy | 8% Sell |
| Previous Opinion | 88% Buy | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 72% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.89% since 04/12/24 | +0.56% since 04/12/24 | -2.41% since 04/12/24 | -1.97% since 11/13/19 | -0.90% since 04/12/24 |
| Low | 17.90 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
| High | 18.09 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | -1.05% since 03/19/24 | -1.09% since 03/19/24 | -9.51% since 03/19/24 | +5.14% since 10/18/19 | -5.35% since 03/19/24 |
| Low | 17.87 on 04/03/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 18.22 on 03/25/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +95.20% since 01/19/24 | -12.68% since 01/19/24 | -23.90% since 01/19/24 | +13.63% since 08/20/19 | -9.66% since 01/19/24 |
| Low | 8.88 on 01/23/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 18.31 on 03/12/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +171.62% since 10/19/23 | -4.22% since 10/19/23 | -15.31% since 10/19/23 | +14.14% since 05/20/19 | +7.73% since 10/19/23 |
| Low | 4.18 on 11/22/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 18.31 on 03/12/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,718,709 | 140,812,720 | 82,374,304 | 77,035,920 | 101,698,464 |
| Shares Outstanding, K | 150,621 | 535,919 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 257,890,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -205,350,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 63,610,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 53,170,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 1.17 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.33 on 03/13/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 29.25 |